New tool aims to catch Parkinson's hidden mood swings
NCT ID NCT04455074
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new questionnaire called the NF-scale, designed to measure sudden mood and thinking changes (neuropsychiatric fluctuations) that can occur in Parkinson disease. 130 French-speaking participants with Parkinson disease and motor fluctuations filled out the questionnaire during both their OFF and ON medication states. The goal was to see if the scale is reliable and accurate for use in clinics and research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If validated, this scale could help doctors better detect and manage mood and thinking fluctuations in Parkinson disease, improving patient care.
What could go wrong
This is a validation study, not a treatment trial. The scale may not prove reliable or useful in routine practice, and results may not apply to non-French speakers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Strasbourg
Strasbourg, 67091, France
-
CHU Amiens
Amiens, 80 054, France
-
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
-
CHU de Bordeaux-Hôpital Pellegrin
Bordeaux, 33 076, France
-
Hospices Civils Lyon (HCL)
Lyon, 69 677, France
-
University hospital grenoble
Grenoble, 38043, France